advertisement
 

  Back to News and Information CDA 2002 Meeting

Children with Diabetes attended the 2002 meeting of the Canadian Diabetes Association, held in Vancouver, British Columbia, from October 3-5. TheraSense generously provided space in their booth for us to show our web site and meet with health care professionals from Canada.

Posters

There were several excellent posters about diabetes care in kids and adults with type 1 diabetes. Here is a selection.

  1. Comparison of CSII and Conventional Treatment of Type 1 Diabetes in Childhood on Quality of Life, Treatment Satisfaction and Metabolic Control reported that "compared to their peers on conventional therapy, children and adolescents who choose to use CSII [pump therapy, Ed.] have significantly better quality of life and treatment satisfaction, independent of their improved metabolic control," and that "CSII should be available to all motivated children and adolescents with type 1 diabetes regardless of their metabolic control, as it is associated with improved physiological and psychological outcomes." [Full Poster, Left Side, Right Side, all images 2560x1920 pixels]

  2. Insuflon - Is It Better Than Sliced Bread? examined whether Insuflon, an indwelling catheter, could improve control and quality of life in children and adolescents. While the study found no improvement in metabolic control, it did find that children who used the Insuflon "improved their sense of health and well-being." [Full Poster, 2560x1920 pixels]

  3. Insulin aspart safe for long-term treatment: A 2 1/2-year, multicentre, open-labelled, parallel-group, extension trial in 753 adult subjects with Type 1 diabetes, from a team at the University of Newcastle at Newcastle upon Tyne in the UK, reported that insulin aspart, known in the US as NovoLog and elsewhere as NovoRapid, was shown to be "a safe and effective treatment for long-term use" and that it showed "a small improvement in glucose control with no deterioration in hypoglycemia or other serious adverse events."

  4. Generex Biotechnology Corporation presented four posters about Oralin, their oral insulin spray. Oral Insulin Spray (Oralin) as Meal Insulin for Treatment of Type-1 Diabetes reported on a trial conducted by a team at the Institute of Endocrinology Iemir in Quito, Equador, that used Oralin, an aerosolized mist insulin taken using a device much like an asthma inhaler. The study concluded that Oralin worked faster than injected insulin [assumed to be human Regular insulin, though not stated. Ed.] and that it proved efficient in controlling post-meal glucose levels.

  5. In Biokinetics of Oral Spray Insulin: Comparison with Regular and Lispro Insulin in Patients with Type-1 Diabetes, a medical team from Rome found that oral spray insulin was effective in lowering blood glucose and that its length of action was more similar to that of lispro insulin (Humalog) than Regular human insulin. [Full Poster, 2560x1920 pixels]

  6. Comparing Early and Late Postprandial Exercise Effect in Type 1 Diabetes Patients concluded that "late postprandial exercise requires more dextrose than early postprandial exercise, in order to maintain safe blood glucose" levels. [Full Poster, 2560x1920 pixels]

Note: Poster images are all over 1 MB in size.

From the Show Floor

Companies that make products for people with diabetes often introduce new and updated products at the diabetes conferences. Here are a few selected highlights:

photo
CWD showed the web site from the TheraSense booth.
[ medium | large ]
photo
The TheraSense booth was packed with people eager to try the FreeStyle meter.
[ medium | large ]
photo
Only the lines for the excellent food were longer.
[ medium | large ]
photo
The exhibit hall opened at 6:30 am to accommodate breakfast visitors.
[ medium | large ]
photo
The A1c Now home HbA1c tester was a big hit.
[ medium | large ]
photo
BD introduced the Latitude, a new blood glucose meter that takes 0.4 microliters of blood and produces results in five seconds. The Latitude is a large device, with room to hold an insulin pen, pen needles, a lancing device, lancets, and a vial of test strips.
[ medium | large ]
photo
LifeScan and NovoNordisk shared space and showed their products.
[ medium | large ]
photo
MediSense introduced a new test strip for the Precision Xtra that uses 1.5 microliters and produces results in 10 seconds.
[ medium | large ]
photo
The poster showing the new BD Latitude meter.
[ medium | large ]


Other Links About CDA 2002

  1. 6th Annual CDA/CSEM Professional Conference

October 6, 2002



                 
  Home Return to Top

Last Updated: Thursday January 09, 2003 08:36:12
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.